Tennessee has been selected as one of four states to participate in a pilot program for delivery of the Pfizer Inc. COVID-19 vaccine now under development. This program is designed to address distribution challenges posed by requirements for ultra-cold storage of the vaccine.
Tennessee will participate in the pilot along with New Mexico, Rhode Island and Texas, states chosen based on their differences in size, population diversity and immunization infrastructure. Lessons learned through this program will help support all states in development of effective immunization programs for this COVID-19 vaccine.
Once the vaccine is approved, Tennessee and other states participating in the pilot will not receive vaccine doses earlier than other states by virtue of the pilot. Pfizer expects to have enough safety data on the vaccine from ongoing trials before the end of November before applying for emergency use authorization. Pfizer is working with Operation Warp Speed and the Centers for Disease Control and Prevention to ensure that following approval, their COVID-19 vaccine can be provided to those most in need as quickly and equitably as possible.
TDH in coordination with other state and local agencies submitted an initial draft of the COVID-19 Vaccination Plan for Tennessee to the CDC on October 16, 2020. This plan will be modified as more is understood about the virus and the availability of approved vaccines currently in development. Tennessee is preparing to begin distribution of COVID-19 vaccine as early as December 2020.
TDH is working to onboard hospitals, pharmacies, clinics and other partners capable of storing vaccine and administering it to priority populations. TDH will ensure distribution of vaccination sites across all 95 counties, especially in rural counties and areas with high concentrations of people in vulnerable populations. Providers who wish to administer COVID-19 vaccine may find more information online at www.tn.gov/health/cedep/ncov/covid-19-vaccine-information.html.